SOD1 and amyotrophic lateral sclerosis: Moreover, Gal-3 has emerged as a key biomarker candidate on account of its differential expression in ALS mouse model SOD1 (G93A) and spinal cord tissue and cerebrospinal fluid from ALS patients (Zhou et al., 2010).